| Name | Title | Contact Details |
|---|
Since 1989, L Catterton`s funds have made over 150 investments in leading consumer brands across all segments of the consumer industry. With over $14 billion of equity capital dedicated to growing middle market companies and emerging high-growth enterprises, we are the largest and most experienced consumer-focused private equity group in the world. We are currently investing globally from six fund platforms.
Fischer Francis Trees is a New York, NY-based company in the Financial Services sector.
Clarion Partners is a leading U.S. real estate investment manager. The Firm is headquartered in New York with a presence in major markets across the United States, as well as in São Paulo, Brazil, London, England and Mexico City. Our organization is built on a broad network of real estate professionals who bring knowledge of local markets to every investment decision. • Investments in high quality properties, typically from the five key property types: office, retail, industrial, multifamily residential and hotel • Broad range of real estate strategies across the risk/return spectrum: core, core-plus, value-add and opportunistic • $43.3 billion in total assets under management • 300+ institutional investors both domestic and international • Investment options in both fund and separate account formats • Expertise in equity and debt structures • 280+ employees • SEC-registered investment advisor • Distinguished investment manager with 35-year history We provide investors with long-term real estate solutions to support their investment objectives, mindful of our obligations of accountability, transparency and trust.
Stone Hilll Partners is a Gatineau, QC-based company in the Financial Services sector.
NaviMed Capital is a Washington, DC-based private capital firm focused exclusively on the healthcare industry. NaviMed makes substantial investments in fast growing lower middle market healthcare businesses. The firm focus on healthcare services, healthcare IT, hospital products, and distribution businesses which are poised to benefit from the reform and technology innovation forces reshaping the healthcare industry. NaviMed targets profitable private companies with up to $10 million of EBITDA and double digit revenue growth. NaviMed seeks investments which can benefit from its deep industry expertise, broad relationship network and combined 50+ year track record of success as healthcare investors and operators. NaviMed`s senior investment team has a track record of value creation spanning dozens of investments and more than $6.5 billion of enterprise value created.